Copyright
©The Author(s) 2019.
World J Hepatol. Jun 27, 2019; 11(6): 542-552
Published online Jun 27, 2019. doi: 10.4254/wjh.v11.i6.542
Published online Jun 27, 2019. doi: 10.4254/wjh.v11.i6.542
Grade | 1-yr AUROC | 3-yr AUROC | Overall AUROC |
TNM | 0.639 | 0.626 | 0.620 |
CTP | 0.672 | 0.649 | 0.643 |
ALBI | 0.741 | 0.728 | 0.709 |
Modified ALBI | 0.755 | 0.732 | 0.719 |
PALBI | 0.753 | 0.741 | 0.734 |
BCLC | 0.758 | 0.743 | 0.713 |
ALBI-based BCLC | 0.762 | 0.751 | 0.749 |
ALBI-T | 0.822 | 0.809 | 0.801 |
Modified ALBI-T | 0.851 | 0.848 | 0.848 |
- Citation: Elshaarawy O, Alkhatib A, Elhelbawy M, Gomaa A, Allam N, Alsebaey A, Rewisha E, Waked I. Validation of modified albumin-bilirubin-TNM score as a prognostic model to evaluate patients with hepatocellular carcinoma. World J Hepatol 2019; 11(6): 542-552
- URL: https://www.wjgnet.com/1948-5182/full/v11/i6/542.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i6.542